{"name": "phoslo.us",
 "permalink": "phoslo-us",
 "crunchbase_url": "http://www.crunchbase.com/company/phoslo-us",
 "homepage_url": "http://www.phoslo.us",
 "blog_url": "http://www.phosl.us",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "advertising",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "health, medicine, drugs",
 "alias_list": null,
 "email_address": "support@universalgenericdrugs.com",
 "phone_number": "18006056854",
 "description": "PhosLo consists of the mineral calcium a",
 "created_at": "Thu Oct 18 10:55:48 UTC 2012",
 "updated_at": "Fri Oct 26 17:16:23 UTC 2012",
 "overview": "\u003Cp\u003EPhosLo consists of the mineral calcium acetate. It is an orally given phosphate binder used in patients with end stage renal disease (ESRD).\u003C/p\u003E\n\n\u003Cp\u003EPhosLo Tablets (calcium acetate) are administered orally for the control of hyperphosphatemia in end stage renal failure.\u003C/p\u003E\n\n\u003Cp\u003EPhosLo, in both capsule and gelcap formulations, has been approved for the control of hyperphosphatemia in end stage renal failure in adult patients.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}